Related Experiment Video

Updated: May 27, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
11:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

Aberrant promoter CpG methylation and its translational applications in breast cancer

Ting-Xiu Xiang1, Ying Yuan, Li-Li Li

  • 1The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

Chinese Journal of Cancer
|November 9, 2011
PubMed

Insights

Epigenetic changes, like DNA methylation, silence tumor suppressor genes (TSGs) in breast cancer. These early changes offer potential for breast cancer early diagnosis and targeted therapy.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Breast cancer development involves genetic and epigenetic alterations.
  • Aberrant gene expression from epigenetic changes, such as promoter methylation and histone modification, is crucial in breast carcinogenesis.
  • Silencing of tumor suppressor genes (TSGs) via promoter CpG methylation promotes cell growth and survival, driving tumor initiation and progression.

Purpose of the Study:

  • To review epigenetic alterations in TSGs relevant to breast cancer pathogenesis.
  • To explore the potential of these epigenetic changes as biomarkers for early breast cancer detection and therapeutic targeting.

Main Methods:

  • This review synthesizes findings from recent studies on epigenetic modifications in breast cancer.
  • Focuses on aberrant promoter methylation and its role in silencing TSGs.
  • Examines the clinical implications of these epigenetic changes.

Main Results:

  • Aberrant promoter methylation of TSGs occurs early in tumorigenesis and can be reversed pharmacologically.
  • These epigenetic alterations contribute significantly to breast cancer initiation and progression.
  • Silenced TSGs due to methylation provide growth and survival advantages to cancer cells.

Conclusions:

  • Epigenetic changes, particularly TSG promoter methylation, are critical in breast cancer.
  • Reversible epigenetic modifications in TSGs present opportunities for early diagnosis.
  • Targeting these epigenetic alterations offers a promising strategy for breast cancer treatment.

More Related Videos

Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...